Wyden Demands Answers from Pfizer Over Lyrica Price Increases

Washington, D.C. – Senate Finance Committee Ranking Member Ron Wyden, D-Ore., called on drug maker Pfizer to justify to the public the continuous price increases it has taken on its drug Lyrica, which is taken by millions of Americans and costs Medicare $2.1 billion every year. “Seniors are paying too much for prescription drugs, threatening […]

Wyden Reveals Opioid Industry Ties on HHS Task Force, Probes Advocacy Group’s Finances

In Separate Letter to U.S. Pain Foundation, Wyden Questions Ties Between Group’s Patient Assistance Program and Embattled Opioid Maker Insys Washington, D.C. – Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today renewed his efforts to shine a light on financial ties between opioid manufacturers, third-party advocacy groups, and government panels that provide outside expertise […]

Wyden Statement on Ruling that Affordable Care Act is Unconstitutional

Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today issued a statement after a Texas District Court judge ruled against the Affordable Care Act, threatening core parts of the law like pre-existing condition protections, tax credits for health care and the Medicaid expansion: “Today’s ruling is an assault on all Americans’ basic health care rights […]

Wyden Statement on Vote to Overturn Treasury’s Pro-Dark Money Rule

Washington, D.C. – Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today delivered a statement on the Senate floor ahead of a vote on his resolution with Senator Jon Tester, D-Mont., to overturn a Treasury ruling that shields the identities of large dark money donors from U.S. tax authorities. “The Trump administration’s dark money rule […]

Wyden. Grassley Announce Bill to Recoup Millions from Pharma Ripoff

After EpiPen Maker Overcharged Taxpayers for Hundreds of Millions of Dollars, Bipartisan Senators Release Legislation to Clamp Down on Misclassification Washington, D.C. – Senate Finance Committee Ranking Member Ron Wyden, D-Ore., and senior Finance Committee member Chuck Grassley, R-Iowa, today introduced a bill that would fix an issue in Medicaid that has allowed pharmaceutical manufacturers […]

Wyden Statement on Signing of NAFTA Update

WASHINGTON—Senator Ron Wyden, D-Ore., the ranking member of the Senate Finance Committee, released the following statement on the signing today of an updated NAFTA agreement with Canada and Mexico: “While there are elements of the revised NAFTA agreement that are clear improvements over the status quo and could set welcome new standards in international trade, […]